GL1X · GenesisL1 explorer

MolNFT v1 · #59560 · protein

Crystal structure of thrombin in complex with inhibitor 15

3C1K · Prothrombin: “Crystal structure of thrombin in complex with inhibitor 15”. X-ray diffraction, 1 ligand (T15), 1 pocket (best druggability 0.54). MolNFT v1 #59560 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3C1K
Type
protein
Length
287 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Prothrombin; Hirugen
EC
3.4.21.5
UniProt
P00734, P28511
Ligands
T15
Pockets
1 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 17% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProthrombin (EC 3.4.21.5)protein27616% helix, 31% strandP00734
BHirugenprotein1136% helix, 0% strandP28511

Ligands and binding sites

  • T15 · 2-{3-[(benzylsulfonyl)amino]-6-methyl-2-oxopyridin-1(2H)-yl}-N-({1-[2-(tert-butylamino)-2-oxoethyl]-4-methyl-1H-imidazol-5-yl}methyl)acetamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12720.540.7642T15

Interfaces

1 interface between chains.

  • A–B · 690 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, sulfation).

Compared structures

  • 3C1K · Crystal structure of thrombin in complex with inhibitor 15 · the same entry in another collection · chain A against A, TM-score 1.00
  • P28511 · AlphaFold monomer V2.0 prediction for hirudin-3B' (P28511) · a predicted model of the same protein · chain B against A, TM-score 0.46

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.